Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01765439 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Aug 2025 to Aug 2027
    • Study completion date: Aug 2026 to Dec 2027
    v14
  2. Primary completion date: Jun 2024 to Aug 2025
    • Study completion date: Mar 2025 to Aug 2026
    v13
  3. Primary completion date: Dec 2022 to Jun 2024
    • Study completion date: Dec 2023 to Mar 2025
    v12
  4. Primary completion date: Dec 2021 to Dec 2022
    • Study completion date: Dec 2022 to Dec 2023
    v11
  5. Primary completion date: Aug 2021 to Dec 2021
    • Study completion date: Feb 2022 to Dec 2022
    v10
Show 8 earlier versionsHide 8 earlier versions
  1. Primary completion date: Aug 2019 to Aug 2021v9 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 80 to confirmed 79
    • Study completion date: Feb 2020 to Feb 2022
    • Site details revised
  2. Primary completion date: Jan 2018 to Aug 2019
    • Study completion date: Aug 2018 to Feb 2020
    v8
  3. Primary completion date: Jan 2017 to Jan 2018
    • Study completion date: Aug 2017 to Aug 2018
    v7
  4. Primary completion date: Jan 2016 to Jan 2017
    • Study completion date: Aug 2016 to Aug 2017
    • Interventions: VSL#3 (Dietary Supplement) to VSL#3 (Original De Simone formulation) (Dietary Supplement)
    • Study description expanded, about 8 words
    v6
  5. Primary completion date: Aug 2015 to Jan 2016
    • Study completion date: Jan 2016 to Aug 2016
    v5
  6. Primary completion date: Dec 2014 to Aug 2015
    • Study completion date: Feb 2015 to Jan 2016
    v4
  7. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Apr 2013 to Feb 2014
    • Site details revised
    v3
  8. Start date: Mar 2013 to Apr 2013
    • Eligibility criteria expanded, about 1 word
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to determine, whether administration of VSL#3 (Original De Simone formulation) probiotic preparation can alter the bile acid metabolism in patients with inflammatory bowel disease.
Trial Details
NCT Number NCT01765439
Lead Sponsor Charles University, Czech Republic
Collaborators: Iscare i.v.f., Czech Republic, CD Investments srl, University Of Perugia, University of Roma La Sapienza
Conditions
(from sponsor)		 Crohn Disease, Ulcerative Colitis
Related terms Colitis, Ulcerative, Crohn Disease
Enrollment 79 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov